Drug intelligence / Profile preview

d-luciferin

Development stage
Unknown
Lead developer
Promega
Modality
Small Molecules
Administration
Intraperitoneal, Intravenous
01

Overview

D-luciferin is a naturally occurring heterocyclic compound that serves as the primary substrate for the enzyme firefly luciferase, derived from the firefly *Photinus pyralis*. In a process requiring ATP, magnesium, and oxygen, luciferase catalyzes the oxidative decarboxylation of D-luciferin to oxyluciferin, a reaction that results in the emission of yellow-green light. This bioluminescent property is extensively utilized in biomedical research for non-invasive bioluminescence imaging (BLI) to monitor biological processes in vivo, such as gene expression, tumor progression, and the efficacy of therapeutic interventions in animal models. While D-luciferin is the standard substrate for BLI, its utility in central nervous system studies is sometimes limited by its relatively poor penetration of the blood-brain barrier, leading to the development of synthetic analogs with improved pharmacological profiles.

Other names
(S)-2-(6-hydroxy-2-benzothiazolyl)-2-thiazoline-4-carboxylic acidfirefly luciferin4,5-dihydro-2-(6-hydroxy-2-benzothiazolyl)-4-thiazolecarboxylic acid

Beyond the preview

Go deeper on d-luciferin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on d-luciferin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call